# Optimizing Smoking Cessation for People With HIV/AIDS Who Smoke

> **NCT02460900** · PHASE3 · COMPLETED · sponsor: **University of Maryland, Baltimore** · enrollment: 184 (actual)

## Conditions studied

- Smoking
- HIV

## Interventions

- **DRUG:** Varenicline
- **BEHAVIORAL:** Positively Smoke Free
- **DRUG:** Placebo
- **BEHAVIORAL:** Standard of Care

## Key facts

- **NCT ID:** NCT02460900
- **Lead sponsor:** University of Maryland, Baltimore
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2016-07
- **Primary completion:** 2021-04
- **Final completion:** 2021-04
- **Target enrollment:** 184 (ACTUAL)
- **Last updated:** 2025-03-13

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02460900

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02460900, "Optimizing Smoking Cessation for People With HIV/AIDS Who Smoke". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT02460900. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*